Several studies analyzed the impact of RAGE in chronic liver disease: Goodwin et al. generated AGE-rat serum albumin (mainly CML) and illustrated that treatment with AGE-rat serum albumin resulted in increased oxidative stress. This evidence concerns the gene ALB and chronic myelogenous leukemia, BCR-ABL1 positive.